| Dr Stanley Babu, MD | |
|
9590 E Ironwood Square Dr Ste 125, Scottsdale, AZ 85258-4583 | |
| (480) 455-3000 | |
| (860) 819-6115 |
| Full Name | Dr Stanley Babu |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 9590 E Ironwood Square Dr Ste 125, Scottsdale, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700935525 | NPI | - | NPPES |
| Z257291 | Other | AZ | DOCTOR OF MEDICINE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 60127 (Arizona) | Primary |
| 207Q00000X | Family Medicine | 048742 (Connecticut) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| 4c Medical Group Plc | 2769653641 | 55 |
| Skilled Facility Health Care Solutions Inc | 9032299144 | 55 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
| Entity Name | Skilled Facility Health Care Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922231828 PECOS PAC ID: 9032299144 Enrollment ID: O20100119000665 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
| Entity Name | 4c Medical Group Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558654384 PECOS PAC ID: 2769653641 Enrollment ID: O20110926000641 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
| Entity Name | Live Life Now Health Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770111429 PECOS PAC ID: 9537581897 Enrollment ID: O20210720003958 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
| Entity Name | Z Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073253712 PECOS PAC ID: 8426445891 Enrollment ID: O20220504000512 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stanley Babu, MD Po Box 35380, Las Vegas, NV 89133-5380 Ph: (702) 954-7500 | Dr Stanley Babu, MD 9590 E Ironwood Square Dr Ste 125, Scottsdale, AZ 85258-4583 Ph: (480) 455-3000 |
News Archive
Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.
A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years of treatment, investigators at Dana-Farber Cancer Institute and other institutions report in a paper published today by the New England Journal of Medicine.
Although approved for use for treating traumatic brain injury (TBI) in nearly 60 countries, use of citicoline in a randomized trial that included more than 1,200 participants with TBI did not result in improvement in functional and cognitive status, according to a study appearing in the November 21 issue of JAMA.
Patients with inflammatory diseases such as rheumatoid arthritis now have many more treatment options than in the past, including biologic disease-modifying antirheumatic drugs (DMARDs).
› Verified 9 days ago
Dr. Sam Saman Fereidouni, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7699 E Pinnacle Peak Rd, Suite 115, Scottsdale, AZ 85255 Phone: 480-300-4663 Fax: 480-300-4888 | |
Dr. Daniel Andrew Wool, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20801 N Scottsdale Rd Suite 205, Scottsdale, AZ 85255 Phone: 480-389-3265 | |
Helene Wechsler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10900 N Scottsdale Rd, Suite 104, Scottsdale, AZ 85254 Phone: 480-990-1564 Fax: 480-990-3298 | |
Natasha Ryan, NMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8412 E Shea Blvd, Suite 101, Scottsdale, AZ 85260 Phone: 480-874-1515 Fax: 480-991-8395 | |
Evan Scot Trost Ix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8328 E. Hartford Dr., Scottsdale, AZ 85255 Phone: 480-214-9720 Fax: 480-214-9722 | |
Katayoun Baniriah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 E Thunderbird Rd, Scottsdale, AZ 85254 Phone: 480-699-7004 Fax: 480-699-6129 | |
Dr. Ronald Lewis Peters, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13951 N Scottsdale Rd, Suite 100, Scottsdale, AZ 85254 Phone: 480-607-7999 Fax: 480-607-7998 |